Pfam Domains GO Terms
| WD40 |
| NLE |
| hematopoietic stem cell homeostasis |
| negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
| inner cell mass cell differentiation |
| regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
| ribosomal large subunit assembly |
| blastocyst formation |
| somitogenesis |
| ribosome assembly |
| ribosomal large subunit biogenesis |
| negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| somite development |
| negative regulation of cysteine-type endopeptidase activity |
| segmentation |
| blastocyst development |
| Notch signaling pathway |
| positive regulation of canonical Wnt signaling pathway |
| positive regulation of Wnt signaling pathway |
| homeostasis of number of cells |
| regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| anterior/posterior pattern specification |
| negative regulation of apoptotic signaling pathway |
| ribonucleoprotein complex assembly |
| skeletal system morphogenesis |
| regulation of cysteine-type endopeptidase activity |
| negative regulation of endopeptidase activity |
| ribonucleoprotein complex subunit organization |
| negative regulation of peptidase activity |
| kidney development |
| regulation of canonical Wnt signaling pathway |
| renal system development |
| ribosome biogenesis |
| negative regulation of mitotic cell cycle |
| urogenital system development |
| regionalization |
| negative regulation of proteolysis |
| regulation of Wnt signaling pathway |
| in utero embryonic development |
| regulation of apoptotic signaling pathway |
| regulation of endopeptidase activity |
| pattern specification process |
| regulation of peptidase activity |
| negative regulation of hydrolase activity |
| ribonucleoprotein complex biogenesis |
| skeletal system development |
| negative regulation of cell cycle |
| regulation of mitotic cell cycle |
| chordate embryonic development |
| embryo development ending in birth or egg hatching |
| regulation of proteolysis |
| organelle assembly |
| negative regulation of catalytic activity |
| cellular protein-containing complex assembly |
| nucleolus |
| negative regulation of apoptotic process |
| anatomical structure formation involved in morphogenesis |
| negative regulation of programmed cell death |
| animal organ morphogenesis |
| embryo development |
| negative regulation of cell death |
| negative regulation of cellular protein metabolic process |
| negative regulation of protein metabolic process |
| epithelium development |
| negative regulation of molecular function |
| regulation of cell cycle |
| negative regulation of signal transduction |
| regulation of hydrolase activity |
| negative regulation of cell communication |
| negative regulation of signaling |
| regulation of apoptotic process |
| protein-containing complex assembly |
| regulation of programmed cell death |
| negative regulation of response to stimulus |
| homeostatic process |
| positive regulation of signal transduction |
| regulation of cell death |
| tissue development |
| positive regulation of cell communication |
| positive regulation of signaling |
| protein-containing complex subunit organization |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Screen | Score |
|---|---|
| Rotenone 20μM R00 exp34 | -2.03 |
| Aminopterin 0.005μM R07 exp335 | -1.77 |
| Tanespimycin 14μM R08 exp527 | -1.73 |
| LB-100 2μM R05 exp210 | 1.76 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 1/1 |
| 909776.0 | 0/1 |
| bile duct | 16/28 |
| blood | 22/28 |
| bone | 20/26 |
| breast | 24/33 |
| central nervous system | 38/56 |
| cervix | 4/4 |
| colorectal | 13/17 |
| esophagus | 13/13 |
| fibroblast | 1/1 |
| gastric | 10/16 |
| kidney | 16/21 |
| liver | 12/20 |
| lung | 51/75 |
| lymphocyte | 14/16 |
| ovary | 21/26 |
| pancreas | 19/24 |
| peripheral nervous system | 13/16 |
| plasma cell | 13/15 |
| prostate | 0/1 |
| skin | 18/24 |
| soft tissue | 7/9 |
| thyroid | 1/2 |
| upper aerodigestive | 16/22 |
| urinary tract | 20/29 |
| uterus | 2/5 |
Expression Distribution